Both in Pharmaceuticals
Phathom Pharmaceuticals vs Tilray Brands
Over the past year PHAT returned −57.9% and TLRY returned −76.1%; their daily moves had a correlation of 0.01.
PHAT −57.9% TLRY −76.1%Growth of $1, one year, split-adjusted
| Metric | PHAT | TLRY |
|---|---|---|
| Price | $5.68 | $2.96 |
| Market cap | $461.7M | $437.5M |
| Today | −1.05% | +11.70% |
| 1 month | −16.2% | −21.7% |
| 6 months | −55.2% | −48.6% |
| Year to date | −65.8% | −67.2% |
| 1 year | −58.6% | −77.4% |
| Revenue growth (YoY) | +71.1% | +22.7% |
| Gross margin | 78.3% | 30.1% |
| Net margin | −16.4% | −16.8% |
| P/E (TTM) | — | — |
| Price / sales | 1.7× | 0.5× |
| Net cash | $17.6M | $16.6M |
| Dividend yield | — | — |
| Volatility (60d) | 72.0% | 50.2% |
| Short % of float | 17.5% | 14.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).